BIRMINGHAM, Ala., Dec. 7 /PRNewswire/ -- BioHorizons Implant Systems, Inc. relocated its global headquarters in Birmingham, Alabama, to a state-of-the- art, 44,000 square foot facility. The new facility, located at 2300 Riverchase Center, houses all administrative services, a newly formed manufacturing facility and a distribution center. The manufacturing facility will include machining, surface treatment and packaging services.
The new facility was required due to tremendous growth and an expanding product offering. BioHorizons' President and CEO Steve Boggan commented, "We have experienced revenue growth of over 25% for each of the last six years and expect this growth rate to continue over the next several years. As a result, a new facility was required to house our expanding administrative and operations team. Further, the expanded facility allows for vertical integration of our product line to realize margin improvement and manufacturing efficiencies." He continued by stating, "Having manufacturing in-house will also allow us to be even more responsive to the needs of our customers."
BioHorizons was founded in 1994 as an incubator company at the University of Alabama at Birmingham. BioHorizons' flagship External Implant System, a patented system of dental implants and related products, was launched in 1997. BioHorizons has a strong product offering of dental implants including internal hex, external hex, straight-walled, tapered, overdenture and one-piece implants. BioHorizons has signed exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. With 217 employees, BioHorizons has grown into one of the largest dental implant companies in the world. The company has a direct sales force in the U.S., Canada, Germany, Spain and United Kingdom. Products are distributed in the rest of the world via a network of independent distributors. The Company was purchased by HealthpointCapital in 2006.
HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the musculoskeletal sector - specifically orthopedics and dental.
With a cumulative 85 years of experience in healthcare technology,
research and private investing, HealthpointCapital helps clients capitalize
on the explosive growth and unique investment opportunities in one of the
fastest growing sectors of the medical device industry.
HealthpointCapital manages $650 million of institutional capital.
For more information, contact:
Copyright©2007 PR Newswire.
All rights reserved